Archives: Contractor Email

Dear Contractor,

In recognising that the FTY programme in 2025/2026 includes a number of significant changes, CPNI has developed a welcome letter which contractors involved in the programme may wish to share with their trainee.  A copy of the letter is available here.  A space is included to allow community pharmacy employers to add a signature.

The letter provides trainees with links to information on the additional services offered in many community pharmacies, and outlines the vision for enhanced clinical service provision in the future.

Should contractors have any questions in relation to the letter or the FTY training programme please get in touch with Ennis.

Kind regards,

Dear Contractor,

This is a reminder that the Community Pharmacy Daily Interventions Survey is underway.

The purpose of this survey is to capture the breadth of non-commissioned activity in community pharmacies, including patient presentations, referrals, advice provided, and phone call consultations. The evidence gathered will demonstrate the vital contribution of community pharmacy teams, highlight unmet needs, and support future funding and service development discussions.

Your participation is essential to ensure this survey reflects the reality of practice and the pressures faced by contractors and their teams.  If your pharmacy has not yet started, you can begin the survey today and run it for a period of one week.  Please ensure that intervention logs are completed daily throughout the survey week and collated into the master form (pdf here or excel here) for submission.

Thank you for your continued support and commitment to showcasing the value of community pharmacy.

Kind regards,

Dear Colleague

The second update of concessionary prices were granted today for September 2025:

Drug	Pack Size	Concessionary Price
Amiodarone 200mg tablets	28	£5.97
Co-careldopa 25mg/100mg tablets	100	£8.38
Co-codamol 30mg/500mg tablets	30	£1.23
Co-codamol 30mg/500mg tablets	100	£4.10
Esomeprazole 20mg gastro-resistant capsules	28	£4.95
Fenofibrate micronised 267mg capsules	28	£5.80
Fexofenadine 180mg tablets	30	£5.00
Ibandronic acid 150mg tablets	1	£2.95
Indapamide 2.5mg tablets	28	£6.98
Latanoprost 50micrograms/ml eye drops	2.5	£1.81
Oxybutynin 5mg tablets	56	£3.67
Propranolol 80mg modified-release capsules	28	£5.94
Repaglinide 1mg tablets	90	£11.17
Sitagliptin 100mg tablets	28	£2.84
Sitagliptin 100mg/5ml oral solution sugar free	150	£21.63

Concessionary prices will be paid against the usual code, no additional endorsements are needed.

Please continue to notify CPNI of any pricing issues you are experiencing via our Medicine Pricing/Supply Reporter.

Concessionary prices are also published on the CPNI website.

Kind regards

Dear Contractor,

This is a reminder that the Community Pharmacy Daily Interventions Survey STARTS TOMORROW.  The purpose of this survey is to record the breadth of non-commissioned activity taking place in pharmacies, including patient presentations, referrals and phone call consultations.  The data collected will provide robust evidence to demonstrate the important contribution of community pharmacy, highlight unmet needs, and support future funding and service development discussions.  CPNI hope to share evidence from this survey with MLAs at the next All-Party Group on Community Pharmacy; this meeting is to provide a wider understanding of the role of community pharmacy teams, highlighting the extent and range of ‘unseen interventions’.

Examples of interventions you may wish to record include:

1. A patient with a sore back presents: you recommend anti-inflammatories and an ice pack, preventing the need to see another healthcare professional.
2. A patient with ringworm presents: you supply an antifungal cream, preventing a GP consultation.
3. Hospital pharmacist calls the pharmacy to speak to the pharmacist regarding a medication reconciliation for a patient.

These types of interactions happen every day in community pharmacy and are exactly the kind of interventions this survey aims to capture.

Your participation is essential to ensure that this survey reflects the reality of practice and the pressures faced by contractors.  Please ensure that intervention logs are completed daily over the survey week and collated into the master form for submission.

Thank you for your continued support and commitment to showcasing the value of community pharmacy.

Kind regards,

For the attention of Community Pharmacies providing the Autumn 2025 Community Pharmacy Vaccination Service (CPVS)

Dear Contractor

COVID-19: PGD Published Flu: PGD and Vaccination Protocol Published The COVID-19 PGD, Flu PGD and Flu Vaccination Protocol for the Autumn 2025 programme have now been uploaded to the CPVS page of the BSO website and will be valid from 6th October 2025.

Reminder: Collaborative Forum for Community Pharmacy Webinar Tonight 7.30pm (Tuesday 23rd September 2025) Topic: Update on the Autumn Vaccination Programme and Living Well TARGET Checklist Brief Intervention Pilot To register please click here.

Kind regards

Dear colleague,

Community Pharmacies recently received a letter signed by Department of Health, Pharmacy Forum NI and CPNI leads encouraging community pharmacies to sign up to the Marie Curie Daffodil Standards.

The recent Palliative Care week highlighted the important role community pharmacy teams play in providing end of life care. A wide range of engagement occurred across the week including MLA visits to local pharmacies, press coverage and social media activity. It was also an opportunity to highlight the Marie Curie Daffodil Standards for Community Pharmacy and the role this initiative plays in supporting local pharmacies providing palliative care provision.

Launched in March 2025 as a joint initiative between the Royal Pharmaceutical Society and Marie Curie, the Daffodil Standards are supported by the Department of Health, Pharmacy Forum NI and CPNI and aim to build on the high level of care already provided to palliative care patients and their families by community pharmacy teams.

The feedback from those signed up to the initiative has been positive, with pharmacists commenting that they would encourage pharmacy teams to get involved, as by doing so they will get additional information and support to help build their confidence in providing palliative care.  Local pharmacists have shared some of the benefits in adopting the Daffodil Standards in this short clip.

I would encourage pharmacy teams to find out more about the Daffodil Standards and how they could further support the highly respected care they provide to patients and families living with a terminal illness in their communities.

Kind regards,